BRAF and neoplasm: This analysis, other than corroborating the anti-glycolytic effect of VMR also in other BRAF-mutated tumour types, uncovered also a previously unrecognised repressive effect on genes belonging to lipid (Supplementary Fig. S7D), nucleotide (Supplementary Fig. S7E, F) and amino acid metabolism pathways (Supplementary Fig. S7G).